Advertisement
BIIB or PTCT or TWST
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BIIB’s FA Score shows that 0 FA rating(s) are green whilePTCT’s FA Score has 0 green FA rating(s), and TWST’s FA Score reflects 0 green FA rating(s).
- BIIB’s FA Score: 0 green, 5 red.
- PTCT’s FA Score: 0 green, 5 red.
- TWST’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BIIB’s TA Score shows that 4 TA indicator(s) are bullish while PTCT’s TA Score has 4 bullish TA indicator(s), and TWST’s TA Score reflects 4 bullish TA indicator(s).
- BIIB’s TA Score: 4 bullish, 4 bearish.
- PTCT’s TA Score: 4 bullish, 6 bearish.
- TWST’s TA Score: 4 bullish, 6 bearish.
Price Growth
BIIB (@Pharmaceuticals: Major) experienced а -3.18% price change this week, while PTCT (@Biotechnology) price change was -12.95% , and TWST (@Medical Specialties) price fluctuated -23.87% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.67%. For the same industry, the average monthly price growth was +4.31%, and the average quarterly price growth was +12.17%.
The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +4.36%. For the same industry, the average monthly price growth was +0.41%, and the average quarterly price growth was -2.29%.
Reported Earning Dates
BIIB is expected to report earnings on Oct 22, 2025.
PTCT is expected to report earnings on Oct 23, 2025.
TWST is expected to report earnings on Nov 24, 2025.
Industries' Descriptions
@Pharmaceuticals: Major (-0.67% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
@Biotechnology (+0.25% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Medical Specialties (+4.36% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| BIIB | PTCT | TWST | |
| Capitalization | 19.2B | 3.6B | 1.55B |
| EBITDA | 2.79B | 839M | -162.85M |
| Gain YTD | -16.460 | 0.532 | -44.825 |
| P/E Ratio | 12.50 | 6.44 | N/A |
| Revenue | 10B | 1.77B | 348M |
| Total Cash | 2.76B | 2.03B | 257M |
| Total Debt | 6.6B | 390M | 80.3M |
BIIB | PTCT | TWST | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 10 | 14 | 52 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 99 Overvalued | 39 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | 100 | |
SMR RATING 1..100 | 73 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 62 | 45 | 93 | |
P/E GROWTH RATING 1..100 | 94 | 34 | 100 | |
SEASONALITY SCORE 1..100 | 85 | 65 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TWST's Valuation (39) in the Biotechnology industry is somewhat better than the same rating for BIIB (90) and is somewhat better than the same rating for PTCT (99). This means that TWST's stock grew somewhat faster than BIIB’s and somewhat faster than PTCT’s over the last 12 months.
TWST's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BIIB (100) and is in the same range as PTCT (100). This means that TWST's stock grew similarly to BIIB’s and similarly to PTCT’s over the last 12 months.
BIIB's SMR Rating (73) in the Biotechnology industry is in the same range as TWST (97) and is in the same range as PTCT (100). This means that BIIB's stock grew similarly to TWST’s and similarly to PTCT’s over the last 12 months.
PTCT's Price Growth Rating (45) in the Biotechnology industry is in the same range as BIIB (62) and is somewhat better than the same rating for TWST (93). This means that PTCT's stock grew similarly to BIIB’s and somewhat faster than TWST’s over the last 12 months.
PTCT's P/E Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for BIIB (94) and is significantly better than the same rating for TWST (100). This means that PTCT's stock grew somewhat faster than BIIB’s and significantly faster than TWST’s over the last 12 months.
| BIIB | PTCT | TWST | |
|---|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 72% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 78% | 2 days ago 83% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 68% | 2 days ago 72% | 2 days ago 84% |
| MACD ODDS (%) | 2 days ago 52% | 2 days ago 80% | 2 days ago 89% |
| TrendWeek ODDS (%) | 2 days ago 71% | 2 days ago 78% | 2 days ago 88% |
| TrendMonth ODDS (%) | 2 days ago 70% | 2 days ago 75% | 2 days ago 86% |
| Advances ODDS (%) | 5 days ago 53% | 6 days ago 74% | 13 days ago 79% |
| Declines ODDS (%) | 11 days ago 70% | 2 days ago 81% | 3 days ago 89% |
| BollingerBands ODDS (%) | 2 days ago 55% | 2 days ago 79% | 2 days ago 80% |
| Aroon ODDS (%) | N/A | 2 days ago 68% | 2 days ago 86% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RMQHX | 633.22 | 11.52 | +1.85% |
| Rydex Monthly Rbl NASDAQ-100® 2x Strt H | |||
| SGZFX | 62.11 | 0.61 | +0.99% |
| Saturna Growth Z | |||
| CBFAX | 40.16 | 0.08 | +0.20% |
| American Funds Global Balanced 529A | |||
| FIWBX | 15.00 | -0.01 | -0.07% |
| Fidelity Advisor Multi-Asset Income Z | |||
| WOOSX | 18.11 | -0.06 | -0.33% |
| JPMorgan SMID Cap Equity R6 | |||